Close Menu
  • Home
  • World News
  • India News
  • Business News
  • Health
  • Sports
  • Indian Diaspora In US
  • Technology
  • Bollywood
  • Education
Facebook X (Twitter) Instagram
Monday, October 26, 2026
Breaking News
  • Foreign Investment Rises, But New Business Ventures Fall: UN Reports at Doha’s World Investment Forum
  • Netherlands Breaks from European Tech Norms as Chipmaker Thrives in AI Surge, Reports ING
  • Kriti Sanon and Varun Dhawan Team Up with Bhediya Director Amar Kaushik, Drop Exciting ‘Obsessed’ Hint!
  • Secrets of Longevity: Discover the Three Daily Rituals of Centenarians in a Small Italian Village
  • Ballon d’Or 2026: How to Catch the Action Live, Key Contenders, and Viewing Details
  • Manipulation: A Sneak Peek from The Times of India
  • Lula da Silva Secures Fourth Presidential Term in Brazil’s Leftist Triumph
  • India Likely to Keep Duty-Free Cotton Imports Open Until December, Sources Reveal — TradingView News
Facebook X (Twitter) Instagram
India Bulletin
Advertisement
  • Home
  • World News
  • India News
  • Business News
  • Health
  • Sports
  • Indian Diaspora In US
  • Technology
  • Bollywood
  • Education
India Bulletin
Home»Technology»Judge Shuts Down OpenAI Lawyers: No Questions for Elon Musk on This Topic
Technology

Judge Shuts Down OpenAI Lawyers: No Questions for Elon Musk on This Topic

March 15, 20263 Mins Read
Facebook Twitter Email
Share
Facebook Twitter Email


Judge Limits Questions in Elon Musk’s Trial Against OpenAI

In a notable ruling, a U.S. judge has decided that Tesla CEO Elon Musk will not have to answer questions about his use of the drug ketamine during his upcoming trial against OpenAI. This ruling was made by Judge Yvonne Gonzalez Rogers, who emphasized that the topic is not relevant to the case at hand. The trial focuses on the ongoing legal battle regarding OpenAI’s shift from a nonprofit structure.

During a recent hearing in Oakland, California, Judge Rogers laid out the topics that would be allowed in the jury trial, which is set to begin on April 28. The case will revisit the early days of OpenAI, Musk’s falling out with the organization, and a massive $13 billion investment from Microsoft.

Musk is claiming that OpenAI co-founders Sam Altman and Greg Brockman misled him about the organization’s nonprofit status when he contributed approximately $38 million in its early days. He is seeking damages that could amount to $134 billion, a claim that both OpenAI and Microsoft deny.

Judge Draws the Line on Ketamine Questions

The judge specifically rejected the idea of questioning Musk about his alleged ketamine use during negotiations with OpenAI. She made it clear that unless stronger evidence is presented regarding the effects of ketamine, the topic would not be relevant. However, she mentioned that Musk’s trips to Burning Man, where drug use occurs, could be touched upon, as there were significant interactions between him and OpenAI during these trips.

OpenAI’s lawyer, William Frentzen, pointed out that Musk struggled to recall whether he had used ketamine during certain negotiation periods. Musk has stated that he used the drug with a prescription in the past but has not used it recently. There are also claims in the media about his recreational drug use.

Key Details on the Trial

In addition to the ketamine issue, Judge Rogers made several important rulings at the hearing. She noted that the jury’s determination for damages will be advisory, meaning she will ultimately decide the final amount. The judge may also prevent Musk from pursuing additional punitive damages. Testimony from Musk’s expert witness, financial economist C. Paul Wazzan, is likely to be allowed. Wazzan earlier suggested that Musk could be entitled to profits between $79 billion and $134 billion based on his early funding of OpenAI.

However, Judge Rogers expressed skepticism toward Wazzan’s conclusions, stating, “Do I find it convincing? Not really, not particularly persuasive.” Lawyers for OpenAI and Microsoft have contested Musk’s claims, arguing that he is seeking an unrealistic amount compared to what he initially invested.

The trial, anticipated to last about four weeks, may feature testimonies from several notable figures in the tech industry, including Musk, Altman, Brockman, and others. The judge has also emphasized that all witnesses, regardless of their fame, will be treated equally in court and must enter through the public entrance. Additionally, both parties will share the responsibility of providing lunch for the jury during their deliberations, a typically court-covered expense. The judge commented, “You have plenty of money to pay for it.”

damages claim by Musk Elon Musk ketamine Elon Musk trial Microsoft investment in OpenAI OpenAI OpenAI ketamine question OpenAI nonprofit structure Sam Altman Satya Nadella Tesla
Share. Facebook Twitter Email
admin
  • Website

Related Posts

Netherlands Breaks from European Tech Norms as Chipmaker Thrives in AI Surge, Reports ING

October 26, 2026

Billionaire Mark Cuban: Embracing AI with a Cockroach Theory Mindset

October 26, 2026

Morrisons Partners with Instacart and Everssen as a Contender for 2026 RTIH Innovation Awards

October 26, 2026
  • Facebook
  • Twitter
  • Instagram
Don't Miss

Foreign Investment Rises, But New Business Ventures Fall: UN Reports at Doha’s World Investment Forum

Netherlands Breaks from European Tech Norms as Chipmaker Thrives in AI Surge, Reports ING

Kriti Sanon and Varun Dhawan Team Up with Bhediya Director Amar Kaushik, Drop Exciting ‘Obsessed’ Hint!

Secrets of Longevity: Discover the Three Daily Rituals of Centenarians in a Small Italian Village

Started in 2004, India Bulletin is the largest and
most read South Asian publication
in Chicago and surrounding Midwest.

  • Home
  • About Us
  • Contact
  • Advertise With Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • CCPA
News
  • Bollywood
  • Business News
  • Health
  • India News
  • Indian Diaspora In US
  • Sports
  • Technology
  • World News
Facebook X (Twitter) Instagram

Type above and press Enter to search. Press Esc to cancel.

Accessibility Adjustments

Powered by OneTap

How long do you want to hide the toolbar?
Hide Toolbar Duration
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content Modules
Font Size

Default

Line Height

Default

Color Modules
Orientation Modules